Total Payments
$36,948
2024 Payments
$34,520
Companies
9
Transactions
43
Medicare Patients
247
Medicare Billing
$20,244
Payment Breakdown by Category
Other$27,903 (75.5%)
Consulting$3,769 (10.2%)
Travel$2,972 (8.0%)
Food & Beverage$2,210 (6.0%)
Education$93.95 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,903 | 5 | 75.5% |
| Consulting Fee | $3,769 | 2 | 10.2% |
| Travel and Lodging | $2,972 | 13 | 8.0% |
| Food and Beverage | $2,210 | 22 | 6.0% |
| Education | $93.95 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $33,070 | 19 | $0 (2024) |
| Eli Lilly and Company | $1,250 | 1 | $0 (2024) |
| Olympus Corporation of the Americas | $1,203 | 8 | $0 (2017) |
| Apollo Endosurgery US Inc | $450.41 | 5 | $0 (2023) |
| Boston Scientific Corporation | $348.77 | 3 | $0 (2024) |
| AbbVie, Inc. | $225.89 | 3 | $0 (2019) |
| Aries Pharmaceuticals, Inc. | $204.50 | 2 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $101.19 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $93.95 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34,520 | 21 | Novo Nordisk Inc ($32,967) |
| 2023 | $243.27 | 2 | Apollo Endosurgery US Inc ($140.66) |
| 2022 | $355.73 | 5 | Apollo Endosurgery US Inc ($309.75) |
| 2019 | $100.89 | 1 | AbbVie, Inc. ($100.89) |
| 2018 | $204.50 | 2 | Aries Pharmaceuticals, Inc. ($204.50) |
| 2017 | $1,523 | 12 | Olympus Corporation of the Americas ($1,203) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,037.50 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $40.20 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Obesity | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,943.75 | General |
| Category: Obesity | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $1,014.66 | General |
| Category: Obesity | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $112.61 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $131.67 | General |
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,487.50 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $49.58 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $329.50 | General |
| Category: Obesity | ||||||
| 06/17/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $2,518.75 | General |
| 06/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,104.25 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $390.93 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $328.34 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $238.19 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $196.24 | General |
| Category: Obesity | ||||||
| 05/10/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 03/27/2024 | Boston Scientific Corporation | APOLLO Revise System (Device) | Food and Beverage | In-kind items and services | $171.12 | General |
| Category: APOLLO Revise System_ENDO | ||||||
| 10/02/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $102.61 | General |
| Category: Obesity | ||||||
| 09/20/2023 | Apollo Endosurgery US Inc | OverStitch Endoscopic Suturing System (Device) | Food and Beverage | In-kind items and services | $140.66 | General |
| Category: ENDOSCOPIC TISSUE APPROXIMATION DEVICE | ||||||
| 11/20/2022 | Boston Scientific Corporation | General - Biopsy (Device) | Food and Beverage | In-kind items and services | $45.98 | General |
| Category: General - Biopsy_ENDO | ||||||
| 11/07/2022 | Apollo Endosurgery US Inc | OverStitch Endoscopic Suturing System (Device), ORBERA Intragastric Balloon System | Food and Beverage | In-kind items and services | $120.12 | General |
| Category: ENDOSCOPIC TISSUE APPROXIMATION DEVICE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 84 | 90 | $40,586 | $7,154 |
| 2021 | 7 | 125 | 133 | $61,846 | $10,103 |
| 2020 | 3 | 38 | 38 | $19,523 | $2,986 |
Total Patients
247
Total Services
261
Medicare Billing
$20,244
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $18,115 | $2,448 | 13.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 18 | 20 | $2,360 | $1,420 | 60.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $9,789 | $1,157 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 24 | $2,577 | $1,067 | 41.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $7,745 | $1,062 | 13.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 19 | 19 | $17,306 | $2,357 | 13.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 31 | 31 | $18,620 | $2,211 | 11.9% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 12 | 12 | $9,201 | $1,627 | 17.7% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 18 | 19 | $10,539 | $1,500 | 14.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 17 | 22 | $2,364 | $1,036 | 43.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 12 | 12 | $2,040 | $843.70 | 41.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 18 | $1,776 | $529.02 | 29.8% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 12 | 12 | $10,714 | $1,411 | 13.2% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 14 | 14 | $7,648 | $1,207 | 15.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 12 | $1,161 | $368.40 | 31.7% |
About Dr. Janese Laster, M.D
Dr. Janese Laster, M.D is a Gastroenterology healthcare provider based in Bangor, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2012. The National Provider Identifier (NPI) number assigned to this provider is 1679839047.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Janese Laster, M.D has received a total of $36,948 in payments from pharmaceutical and medical device companies, with $34,520 received in 2024. These payments were reported across 43 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($27,903).
As a Medicare-enrolled provider, Laster has provided services to 247 Medicare beneficiaries, totaling 261 services with total Medicare billing of $20,244. Data is available for 3 years (2020–2022), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Bangor, ME
- Active Since 04/10/2012
- Last Updated 10/22/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679839047
Products in Payments
- Wegovy (Drug) $30,551
- EVIS EXERA (Device) $1,023
- OverStitch Endoscopic Suturing System (Device) $450.41
- Humira (Biological) $225.89
- ELEVIEW (Device) $204.50
- Olympus EMR & ESD Devices (Device) $180.28
- APOLLO Revise System (Device) $171.12
- XIFAXAN (Drug) $101.19
- REMICADE (Biological) $93.95
- General - Biopsy (Device) $45.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bangor
Tahira Saifuddin, Md, MD
Gastroenterology — Payments: $141,585
Gastroenterology $141,585
Brian Berberian, M.d, M.D
Gastroenterology — Payments: $66,592
Gastroenterology $66,592
Angeli Chopra, M.d, M.D
Gastroenterology — Payments: $6,500
Gastroenterology $6,500
Dr. Theodore James, M.d, M.D
Gastroenterology — Payments: $4,894
Gastroenterology $4,894
Joseph Gallagher, Md, MD
Gastroenterology — Payments: $1,872
Gastroenterology $1,872
Mark Lena, Md, MD
Gastroenterology — Payments: $983.96
Gastroenterology $983.96